https://redir.folha.com.br/redir/online/emcimadahora/rss091/*https://www1.folha.uol.com.br/equilibrioesaude/2026/10/anvisa-aprova-5-novas-canetas-para-diabetes-e-obesidade-total-chega-a-19-em-2026.shtml
Anvisa approved five new weight-loss pens using liraglutida and semaglutida. These drugs treat type 2 diabetes and obesity. Total approved pens will reach 19 by 2026.
#diabetes #obesity #anvisa #medicines
Anvisa approved five new weight-loss pens using liraglutida and semaglutida. These drugs treat type 2 diabetes and obesity. Total approved pens will reach 19 by 2026.
#diabetes #obesity #anvisa #medicines
Views: 6
Categories: News & Updates [c3], Projects & Resources [c5]